home
about us
member log-in
contact us

PRODUCTS
MUNICIPAL BONDS
INDEX FUNDS
- Total Asset Fund (TAF)
EVENTS
MARKET RESEARCH

Recent Quotes

View Full List

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Edwards Lifesciences (NY:EW)

84.26 +2.62 (+3.21%)

Official Closing Price Updated: 7:00 PM EDT, Mar 9, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Edwards Lifesciences

< Previous 1 2

...

11 12 13 14 15 16 17 18 19

...

21 22 Next >

$100 Invested In This Stock 10 Years Ago Would Be Worth $700 Today ↗

July 28, 2023

Via Benzinga

Why Willis Towers Watson Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

July 27, 2023

Gainers Femasys Inc. (NASDAQ: FEMY) gained 54% to $0.55. Femasys reported a notice of allowance for new U.S. patent application covering use of FemBloc for female permanent birth control.

Via Benzinga

Looking Into Edwards Lifesciences's Recent Short Interest ↗

July 24, 2023

Via Benzinga

P/E Ratio Insights for Edwards Lifesciences ↗

July 18, 2023

Via Benzinga

Where Edwards Lifesciences Stands With Analysts ↗

July 14, 2023

Via Benzinga

US Stocks Buckle Up For Solid Open On Meta's Earnings Boost, Fed Relief — But Analyst Advises Some 'Value-Style' Rebalancing ↗

July 27, 2023

Stocks could be heading to a higher open on Thursday, as traders digest some positive earnings reports and look ahead to another batch of economic data.

Via Benzinga

eBay, Barclays, Edwards Lifesciences And Other Big Stocks Moving Lower In Thursday's Pre-Market Session ↗

July 27, 2023

U.S. stock futures traded higher this morning on Thursday. Here are some big stocks recording losses in today’s pre-market trading session. TPI Composites, Inc. (NASDAQ: TPIC) shares declined 20.3% to...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

July 26, 2023

Via Benzinga

Here's How Much You Would Have Made Owning Edwards Lifesciences Stock In The Last 15 Years ↗

July 11, 2023

Via Benzinga

Peering Into Edwards Lifesciences's Recent Short Interest ↗

July 07, 2023

Via Benzinga

Analyst Ratings for Edwards Lifesciences ↗

June 27, 2023

Via Benzinga

Edwards Lifesciences Sinks Despite An Earnings Beat, Outlook Increase ↗

July 26, 2023

Edwards Lifesciences stock fell after the medtech company reported Q2 earnings.

Via Investor's Business Daily

US Stock Futures Signal Shaky Open On Mixed Tech Earnings: Analyst Expects Fed To Adopt 'Wait-And-See' Rate Approach ↗

July 26, 2023

The market mood could remain cautious until the Fed decision and mixed reaction to tech earnings could also weigh down on sentiment.

Via Benzinga

Jim Cramer Says This Major Automotive Stock Is Just Too Cheap: 'That's Wrong. I Think You've Got A Winner' ↗

July 20, 2023

On CNBC’s "Mad Money Lightning Round," Jim Cramer said Tripadvisor, Inc. (NASDAQ: TRIP) is not good enough, and he prefers Booking Holdings Inc. (NASDAQ: BKNG).

Via Benzinga

Here's How Much You Would Have Made Owning Edwards Lifesciences Stock In The Last 10 Years ↗

June 26, 2023

Via Benzinga

$1000 Invested In This Stock 10 Years Ago Would Be Worth $7,400 Today ↗

June 08, 2023

Via Benzinga

The Latest Analyst Ratings for Edwards Lifesciences ↗

May 30, 2023

Via Benzinga

$100 Invested In This Stock 10 Years Ago Would Be Worth $800 Today ↗

May 24, 2023

Via Benzinga

Will Investors Notice Exciting Sign On Edwards Lifesciences's Chart? ↗

May 11, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For July 19, 2023 ↗

July 19, 2023

Via Benzinga

Illumina Takes AI to Genomics: Launch of PrimateAI-3D for Accurate Disease Prediction ↗

June 02, 2023

Illumina, Inc. (NASDAQ: ILMN) launched PrimateAI-3D, an artificial intelligence (AI) algorithm that predicts disease-causing genetic mutations in patients.

Via Benzinga

10 Health Care Stocks With Whale Alerts In Today's Session ↗

May 12, 2023

Via Benzinga

Here's How Much $1000 Invested In Edwards Lifesciences 10 Years Ago Would Be Worth Today ↗

May 09, 2023

Via Benzinga

Piper Sandler Maintains Neutral Rating for Edwards Lifesciences: Here's What You Need To Know ↗

April 27, 2023

Via Benzinga

This Is What Whales Are Betting On Edwards Lifesciences ↗

April 26, 2023

Via Benzinga

3 Medical Device Stocks Outpacing the Healthcare Industry This Year ↗

May 01, 2023

All three of these companies have seen double-digit increases in their share prices this year.

Via The Motley Fool

Market Rally Wobbles Amid Big Earnings Moves From Microsoft, Meta, Crocs, Cloudflare: Weekly Review ↗

April 28, 2023

Microsoft, Meta, Cloudflare and Crocs were among the many big movers.

Via Investor's Business Daily

10 Health Care Stocks With Whale Alerts In Today's Session ↗

April 27, 2023

Via Benzinga

10 Health Care Stocks With Whale Alerts In Today's Session ↗

April 26, 2023

Via Benzinga

eBay To Rally Around 30%? Here Are 10 Other Analyst Forecasts For Tuesday ↗

April 25, 2023

B of A Securities cut the price target for Catalent, Inc. (NYSE: CTLT) from $78 to $49. B of A Securities analyst Derik De Bruin maintained a Neutral rating. Catalent shares fell 0.2% to $44.83 in...

Via Benzinga

< Previous 1 2

...

11 12 13 14 15 16 17 18 19

...

21 22 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Home
About Us
Products
Municipal Bonds
Index Funds
Seminars & Events
Market Research
Contact Us
Member Section
Privacy Policy
Terms & Conditions
Security Notice
Customer Service

Securities offered through Purshe Kaplan Sterling Investments, member FINRA / SIPC, Headquartered at 80 State Street,
Albany, NY 12207
Purshe Kaplan Sterling Investments and Tamar Securities, LLC are not affiliated companies.
Tamar Securities, LLC is a Registered Investment Adviser. Advisory services are only offered to clients or prospective clients where Tamar Securities, LLC
and its representatives are properly licensed or exempt from licensure. Past performance is no guarantee of future returns. Investing involves risk and possible loss of principal capital.
No advice may be rendered by Tamar Securities, LLC unless a client service agreement is in place.

NOT FDIC INSURED. NOT BANK GUARANTEED. MAY LOSE VALUE, INCLUDING LOSS OF PRINCIPAL. NOT INSURED BY ANY STATE OR FEDERAL AGENCY.
Web development by IBCnet.com